{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:27:10Z","timestamp":1788571630179,"version":"build-2803163510"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.11363","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T15:01:07Z","timestamp":1652194867000},"page":"e2211363","source":"Crossref","is-referenced-by-count":34,"title":["Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use"],"prefix":"10.1001","volume":"5","author":[{"given":"Kevin Y.","family":"Xu","sequence":"first","affiliation":[{"name":"Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie M.","family":"Mintz","sequence":"additional","affiliation":[{"name":"Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ned","family":"Presnall","sequence":"additional","affiliation":[{"name":"Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Bierut","sequence":"additional","affiliation":[{"name":"Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri"},{"name":"Alvin J. Siteman Cancer Center, Barnes Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Grucza","sequence":"additional","affiliation":[{"name":"Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri"},{"name":"Departments of Family and Community Medicine and Health and Outcomes Research, St. Louis University, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"issue":"1","key":"zoi220339r1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ADM.0000000000000667","article-title":"What will it take to stem the tide: understanding and addressing the needs of people with addiction involving multiple substances.","volume":"15","author":"Lin","year":"2021","journal-title":"J Addict Med"},{"issue":"6","key":"zoi220339r2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013-2019.","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"zoi220339r3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/add.v116.1","article-title":"Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.","volume":"116","author":"Lin","year":"2021","journal-title":"Addiction"},{"issue":"2","key":"zoi220339r4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ADM.0000000000000726","article-title":"Associations between polysubstance use patterns and receipt of medications for opioid use disorder among adults in treatment for opioid use disorder.","volume":"15","author":"Ford","year":"2021","journal-title":"J Addict Med"},{"issue":"3","key":"zoi220339r5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"key":"zoi220339r6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2019.02.031","article-title":"Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.","volume":"200","author":"Morgan","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"zoi220339r7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.7326\/L19-0145","article-title":"The next stage of buprenorphine care for opioid use disorder.","volume":"170","author":"Martin","year":"2019","journal-title":"Ann Intern Med"},{"issue":"12","key":"zoi220339r8","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1111\/acer.12581","article-title":"Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients.","volume":"38","author":"Spagnolo","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"zoi220339r9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/add.2006.101.issue-4","article-title":"Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review.","volume":"101","author":"Johansson","year":"2006","journal-title":"Addiction"},{"issue":"12","key":"zoi220339r10","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1038\/npp.2013.143","article-title":"Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.","volume":"38","author":"Comer","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"13","key":"zoi220339r11","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s00213-017-4607-8","article-title":"Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.","volume":"234","author":"Roche","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"zoi220339r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108886","article-title":"An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders.","volume":"226","author":"Mintz","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"6960","key":"zoi220339r14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/bmj.309.6960.997","article-title":"Methadone maintenance treatment in opiate dependence: a review.","volume":"309","author":"Farrell","year":"1994","journal-title":"BMJ"},{"issue":"7","key":"zoi220339r16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1176\/appi.ajp.2020.20081174","article-title":"Association between benzodiazepine or Z-drug prescriptions and drug-related poisonings among patients receiving buprenorphine maintenance: a case-crossover analysis.","volume":"178","author":"Xu","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"15","key":"zoi220339r17","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Analysis of recurrent event data under the case-crossover design with applications to elderly falls.","volume":"27","author":"Luo","year":"2008","journal-title":"Stat Med"},{"issue":"10118","key":"zoi220339r18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"zoi220339r19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12888-017-1415-y","article-title":"Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine.","volume":"17","author":"Heikman","year":"2017","journal-title":"BMC Psychiatry"},{"key":"zoi220339r20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: lowering the treatment thresholds.","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi220339r21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/add.2004.99.issue-4","article-title":"Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).","volume":"99","author":"Digiusto","year":"2004","journal-title":"Addiction"},{"key":"zoi220339r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108583","article-title":"Identifying individuals with opioid use disorder: validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse.","volume":"221","author":"Lagisetty","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"zoi220339r23","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/archpsyc.58.11.1065","article-title":"Patterns and predictors of treatment seeking after onset of a substance use disorder.","volume":"58","author":"Kessler","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"zoi220339r12","unstructured":"O\u2019Neil? G, Hulse? G, Arnold-Reed? D, . Naltrexone in treatment of amphetamines, cannabis, and benzodiazepines. Accessed April 5, 2022. https:\/\/nida.nih.gov\/international\/abstracts\/naltrexone-in-treatment-amphetamines-cannabis-benzodiazepines"},{"key":"zoi220339r15","unstructured":"National Center for Injury Prevention and Control Division of Unintentional Injury Prevention. Prescription drug overdose data and statistics: guide to ICD-9-CM and ICD-10 codes related to poisoning and pain. Revised August 2013. Accessed April 5, 2022. https:\/\/stacks.cdc.gov\/view\/cdc\/59394"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2792121\/xu_2022_oi_220339_1651594518.73386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T15:01:10Z","timestamp":1652194870000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2792121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.11363","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]}}}